Vensana Capital — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Tybrhealth develops the B3 GEL™ System, a protective gel applied during tendon and ligament repair surgery to reduce post-operative scar formation and preserve tissue mobility.
BiotechHealthtechMedical DevicesHouston, US
Tim Keane(Founder)inAlex Smith(Founder)inJeffrey Tyber(Director)Stephen Ramon(Executive Officer)Timothy J. Keane, Jr.(Executive Officer, Director)
BoardToby Hamilton(Director)
Board seatGreg Banker· per SEC Form D
Co-investorsAsymmetry VenturesY CombinatorMutual Capital PartnersVentureSouq
BiotechSan Carlos, US
Surag Mantri(Executive Officer, Director)
BoardMatthew Sprinkel(Director)Amir Abolfathi(Director)Varun Gupta(Director)
Board seatJustin Klein· per SEC Form D
Co-investorsBoutique Venture PartnersLongitude CapitalNeotribe Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.